Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Guray SAYDAM"'
Autor:
Esma Evrim Dogan, Aysenur Arslan, Naciye Demirel, Demet Aydin, Ilknur Mansuroglu, Suheyla Atak, Fatma Keklik Karadag, Rafet Eren, Guray Saydam
Publikováno v:
Bulletin of the National Research Centre, Vol 46, Iss 1, Pp 1-14 (2022)
Abstract Background Multiple myeloma (MM) is characterized by infiltration of neoplastic plasma cells in the bone marrow. Although many novel agents have been developed in the last decade, MM remains a non-curable disease. The association between bon
Externí odkaz:
https://doaj.org/article/86604a17b20f42c089ac157e51eb16bf
Publikováno v:
HemaSphere, Vol 7, p e184481b (2023)
Externí odkaz:
https://doaj.org/article/14b5629a3a18408885bff5b87ed3499d
Publikováno v:
Medicine Science, Vol 7, Iss 4, Pp 813-6 (2018)
It is well known that obesity is associated with insulin resistance (IR), and IR may interact with platelet functions. Aging is also associated with (IR) and enhanced platelet aggregation (PA). Though platelet reactivity has been investigated in fema
Externí odkaz:
https://doaj.org/article/77e24eb9101646b997d9db43978e96f9
Autor:
Francesco Passamonti, Francesca Palandri, Guray Saydam, Jeannie Callum, Timothy Devos, Paola Guglielmelli, Alessandro M Vannucchi, Evren Zor, Mike Zuurman, Geralyn Gilotti, Yifan Zhang, Martin Griesshammer
Publikováno v:
The Lancet Haematology. 9:e480-e492
Background The phase 3b, randomised, open-label RESPONSE-2 study in patients with inadequately controlled polycythaemia vera without splenomegaly showed superiority of the Janus kinase (JAK) 1 and JAK2 inhibitor ruxolitinib versus best available ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fb6a002e4e7540a9afcaa9b76fd3719
https://doi.org/10.1016/s2352-3026(22)00102-8
https://doi.org/10.1016/s2352-3026(22)00102-8
Autor:
Cagla Kayabasi, Sunde Yilmaz Susluer, Tugce Balci Okcanoglu, Besra Ozmen Yelken, Zeynep Mutlu, Bakiye Goker Bagca, Cansu Caliskan Kurt, Guray Saydam, Cenk Durmuskahya, Husniye Kayalar, Ahmet Ozbilgin, Cigir Biray Avci, Cumhur Gunduz
Publikováno v:
Nutrition and Cancer. 74:3679-3691
Origanum sipyleum is used in folk medicine due to its anti-inflammatory, antimicrobial, and antioxidant properties. Ponatinib, an effective tyrosine kinase inhibitor in the treatment of chronic myeloid leukemia (CML), has severe side effects. Thus, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2102f2aa5a4ddfcd9cbefc1ceabb6c27
https://doi.org/10.1080/01635581.2022.2077969
https://doi.org/10.1080/01635581.2022.2077969
Autor:
Asu Fergun Yilmaz, Nur Soyer, Nazan Ozsan, Seckin Cagirgan, Ajda Gunes, Melda Comert, Fahri Sahin, Guray Saydam, Nur Selvi Gunel, Filiz Vural
Publikováno v:
Case Reports in Hematology, Vol 2017 (2017)
Myeloid or granulocytic sarcoma (GS) is a tumoral lesion consisting of immature granulocytic cells. It is a rare entity during the course of CML patients especially after allogeneic stem cell transplantation (SCT). Relapse without bone marrow involve
Externí odkaz:
https://doaj.org/article/61365041674e4dd38fa3fcfd57014074
Autor:
Guray Saydam, Ali Unal, Ibrahim Celalettin Haznedaroglu, Abdullah Hacihanifioglu, Ozgur Mehtap, Erdal Kurtoglu, Mesut Gocer, Mehmet Turgut, Engin Kelkitli, Memis Hilmi Atay, Nil Guler, Basak Unver Koluman, Mehmet Sonmez, Nergiz Erkut, Emin Kaya, Irfan Kuku, Mehmet Ali Erkurt, Gulsum Ozet, Funda Ceran, Fahri Sahin, Nur Soyer, Meliha Nalcaci, Mehmet Yilmaz, Sirac Bozkurt, Birkan Aver, Begum Ozdengulsun, Egemen Ozbilgili, Osman Ilhan
Publikováno v:
International Journal of Hematologic Oncology. 11
This study aimed to identify patient characteristics, treatment patterns and outcomes and to evaluate the effects of presence of comorbidities at diagnosis in chronic phase (CP)-chronic myeloid leukemia (CML) patients in Turkey.Hospital records betwe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7d3c2db11c324a5197b8a9728140fed
https://doi.org/10.2217/ijh-2021-0008
https://doi.org/10.2217/ijh-2021-0008
Autor:
Marcelo Capra, Fangfang Lv, Wei Li, Tongyu Lin, Eduardo Yañez, Jifeng Feng, Aryan Hamed, Xiaoling Li, Toshiki Uchida, Ming-Chung Wang, Koji Izutsu, Antonio Salar, Katya Sapunarova, Guray Saydam, Jan Zaucha, Lidia Mongay Soler, Shalini Chaturvedi, Anjun Cao, Barrett H Childs, Pier Luigi Zinzani, Matthew J Matasar
Publikováno v:
Blood Cancer Discovery. 3:A32-A32
Introduction: In the Phase III CHRONOS-3 trial investigating the efficacy and safety of the PI3K inhibitor copanlisib in combination with rituximab (C+R), superior efficacy in progression-free survival (PFS) was demonstrated vs placebo plus rituximab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ea8ee0ba173a4ff09ca8cd98cfd6c9e
https://doi.org/10.1158/2643-3249.lymphoma22-a32
https://doi.org/10.1158/2643-3249.lymphoma22-a32
Publikováno v:
Turkish Journal of Hematology, Vol 30, Iss 4, Pp 351-358 (2013)
OBJECTIVE: here have been tremendous changes in treatment and follow-up of patients with chronic myeloid leukemia (CML) in the last decade. Especially, regular publication and updating of NCCN and ELN guidelines have provided enermous rationale and b
Externí odkaz:
https://doaj.org/article/d57fdb2aed9a437eb82333e748c2eb46
Periferik T cell Lenfomalı Hastalarda Belinostat Deneyimi; Çok Merkezli Gerçek Yaşam Verisi, Türkiye
Autor:
Aydan AKDENİZ, Fatma KEKLİK KARADAĞ, Figen ATALAY, Burak DEVECİ, Mine MİSKİOĞLU, Pelin AYTAN, Guray SAYDAM
Publikováno v:
OSMANGAZİ JOURNAL OF MEDICINE.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b21df11d1f089680d96202f0792d245c
https://doi.org/10.20515/otd.1038937
https://doi.org/10.20515/otd.1038937